← FDA DRUG APPROVALS

FDA ANDA · ANDA073479

PENTAMIDINE ISETHIONATE

Sponsor: HOSPIRA

APPLICATION
ANDA073479
TYPE
ANDA
ORIGINAL APPROVAL
1992-06-30
LATEST ACTION
2002-04-10
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PENTAMIDINE ISETHIONATEDiscontinued
PENTAMIDINE ISETHIONATE 300MG/VIAL · INJECTABLE · INJECTION

Approval history

2002-04-10Manufacturing (CMC) · Supplement 9AP
2002-03-12Manufacturing (CMC) · Supplement 10AP
1999-05-27Labeling · Supplement 8AP
1998-12-09Manufacturing (CMC) · Supplement 7AP
1996-11-20Labeling · Supplement 4AP
1995-06-12Manufacturing (CMC) · Supplement 3AP
1993-07-15Labeling · Supplement 2AP
1993-06-01Manufacturing (CMC) · Supplement 1AP
1992-06-30OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →